-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EL+mZYds8FXWnKlk1M4VWM9oHYv9A4ku2hZ0SQDRZ116vkWtHxuFW5xBNjONGYbs
 hSih/tFcxyFu8lEehR8ZBQ==

<SEC-DOCUMENT>0001179022-04-000022.txt : 20040109
<SEC-HEADER>0001179022-04-000022.hdr.sgml : 20040109
<ACCEPTANCE-DATETIME>20040109114211
ACCESSION NUMBER:		0001179022-04-000022
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040108
FILED AS OF DATE:		20040109

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MJALLI ADNAN M M
		CENTRAL INDEX KEY:			0001275596

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23047
		FILM NUMBER:		04517005

	BUSINESS ADDRESS:	
		STREET 1:		4170 MENDENHALL OAKS PARKWAY
		STREET 2:		SUITE 110
		CITY:			HIGHPOINT
		STATE:			NC
		ZIP:			27265
		BUSINESS PHONE:		3368410300

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGA TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001010086
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133864870
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVE
		STREET 2:		SUITE 601
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
		BUSINESS PHONE:		2126729100

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVE
		STREET 2:		SUITE 601
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGA PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19961108
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>3</documentType><periodOfReport>2004-01-08</periodOfReport>
    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001010086</issuerCik>
        <issuerName>SIGA TECHNOLOGIES INC</issuerName>
        <issuerTradingSymbol>SIGA</issuerTradingSymbol></issuer><reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001275596</rptOwnerCik>
            <rptOwnerName>MJALLI ADNAN M M</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O TRANSTECH PHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>4170 MENDENHALL OAKS PARKWAY, SUITE 110</rptOwnerStreet2>
            <rptOwnerCity>HIGH POINT</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>27265</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
<isDirector>1</isDirector><isOfficer>0</isOfficer><isTenPercentOwner>1</isTenPercentOwner><isOther>0</isOther></reportingOwnerRelationship></reportingOwner><nonDerivativeTable><nonDerivativeHolding><securityTitle><value>Common Stock, par value $0.0001 per share (&quot;Common Stock&quot;)</value></securityTitle><postTransactionAmounts><sharesOwnedFollowingTransaction><value>3472222</value></sharesOwnedFollowingTransaction></postTransactionAmounts><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>by TransTech Pharma, Inc.</value><footnoteId id="F1"/></natureOfOwnership></ownershipNature></nonDerivativeHolding></nonDerivativeTable><derivativeTable><derivativeHolding><securityTitle><value>Warrant (right to buy)</value></securityTitle><conversionOrExercisePrice><value>2.00</value></conversionOrExercisePrice><exerciseDate><value>2004-01-08</value></exerciseDate><expirationDate><value>2011-01-08</value></expirationDate><underlyingSecurity><underlyingSe
curityTitle><value>Common Stock</value></underlyingSecurityTitle><underlyingSecurityShares><value>1736111</value></underlyingSecurityShares></underlyingSecurity><ownershipNature><directOrIndirectOwnership><value>I</value></directOrIndirectOwnership><natureOfOwnership><value>by TransTech Pharma, Inc.</value><footnoteId id="F1"/></natureOfOwnership></ownershipNature></derivativeHolding></derivativeTable><footnotes><footnote id="F1">The shares of Common Stock and the warrants are beneficially owned by TransTech Pharma, Inc.  The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc.  He disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.</footnote></footnotes><remarks/><ownerSignature><signatureName>Adnan M. M. Mjalli</signatureName><signatureDate>2004-01-09</signatureDate></ownerSignature></ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
